Integrated FDG PET-CT imaging improves staging in malignant pleural mesothelioma

Area of Science:

• Oncology
• Radiology
• Diagnostic Imaging

Background:

• Malignant pleural mesothelioma (MPM) staging is crucial for treatment planning.
• Computed tomography (CT) alone may have limitations in accurately staging MPM.

Purpose of the Study:

• To evaluate the frequency of TNM staging changes in MPM patients using integrated PET-CT versus CT alone.
• To determine the clinical relevance of these staging discrepancies.

Main Methods:

• A study of 17 MPM patients (mean age 68 years, 8 women).
• All patients underwent integrated PET-CT scans and histological confirmation.
• TNM staging was compared between CT and PET-CT findings.

Main Results:

• PET-CT revealed TNM classification discrepancies in 47% of patients compared to CT alone.
• Half of these discrepancies (50%) were clinically relevant, leading to downstaging in 29% and upstaging in 18%.
• Higher mean standardized uptake values (SUV) in sarcomatoid MPM and a trend towards longer survival with lower SUV.

Conclusions:

• Integrated PET-CT is a valuable tool for staging MPM, revealing discordant findings in nearly half of patients compared to CT alone.
• These PET-CT-based staging differences frequently have clinical relevance and influence therapeutic strategies for MPM.